{
    "1676877457276690432": {
        "author_id": "5383942",
        "created_at": "2023-07-06T08:55:15.000Z",
        "edit_history_tweet_ids": [
            "1676877457276690432"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 80,
                    "normalized_text": "GSK",
                    "probability": 0.7384,
                    "start": 78,
                    "type": "Organization"
                },
                {
                    "end": 160,
                    "normalized_text": "malaria",
                    "probability": 0.6822,
                    "start": 154,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 161,
                    "start": 153,
                    "tag": "malaria"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.to/3JMGjZ9",
                    "end": 244,
                    "expanded_url": "https://gsk.to/3JMGjZ9",
                    "start": 221,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/behind-the-science-magazine/malaria-vaccine-children-mosquitos-single-dose-treatment/",
                    "url": "https://t.co/jLBiahn24Q"
                }
            ]
        },
        "id": "1676877457276690432",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 2,
            "impression_count": 5553,
            "like_count": 21,
            "quote_count": 1,
            "reply_count": 2,
            "retweet_count": 6
        },
        "text": "\u201cWe\u2019re not dealing with a static enemy\u2026 we have to stay on top of this.\u201d \n\nAt GSK, we\u2019ve been uniting our science, technology and talent to get ahead of #malaria for over 70 years, and we\u2019re not stopping. Find out more \ud83d\udc47 https://t.co/jLBiahn24Q"
    }
}